Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Loriot

Showing results (11-20 of 76) with videos related to

Pageof 8
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 19, 2012
How to select amongst available options for the treatment of advanced RCC?B Escudier, L Albiges, C Massard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 30, 2008
Acute exacerbation of hemorrhagic rectocolitis during antiangiogenic therapy with sunitinib and sorafenibY Loriot, P Boudou-Rouquette, B Billemont, et al.
Bulletin Du Cancer|May 13, 2009
[Molecular aspects of head and neck, and lung cancer oncogenesis]Y Loriot, P Mordant, P Fouret, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 15, 2010
How to select targeted therapy in renal cell cancerB Escudier, L Albiges, A Blesius, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 7, 2010
FGFR inhibitor induced peripheral neuropathy in patients with advanced RCCY Loriot, C Massard, E Angevin, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|June 14, 2011
[Cancer stem cells: a new target for lung cancer treatment]S Rivera, C Rivera, Y Loriot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 14, 2015
EGFR-independent mechanisms of acquired resistance to AZD9291 in EGFR T790M-positive NSCLC patientsD Planchard, Y Loriot, F André, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 9, 2015
Enzalutamide and sleep apnea: an emerging central nervous system side-effect?F Labrize, L Cany, C Massard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 31, 2009
Combining carboplatin and etoposide in docetaxel-pretreated patients with castration-resistant prostate cancer: a prospective study evaluating also neuroendocrine featuresY Loriot, C Massard, M Gross-Goupil, et al.
Prostate Cancer and Prostatic Diseases|January 4, 2017
Skeletal-related events significantly impact health-related quality of life in metastatic castration-resistant prostate cancer: data from PREVAIL and AFFIRM trialsF Saad, C Ivanescu, D Phung, et al.
Pageof 8

Showing results (11-20 of 76) with videos related to

Sort By:
Pageof 8
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 19, 2012
How to select amongst available options for the treatment of advanced RCC?B Escudier, L Albiges, C Massard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 30, 2008
Acute exacerbation of hemorrhagic rectocolitis during antiangiogenic therapy with sunitinib and sorafenibY Loriot, P Boudou-Rouquette, B Billemont, et al.
Bulletin Du Cancer|May 13, 2009
[Molecular aspects of head and neck, and lung cancer oncogenesis]Y Loriot, P Mordant, P Fouret, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 15, 2010
How to select targeted therapy in renal cell cancerB Escudier, L Albiges, A Blesius, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 7, 2010
FGFR inhibitor induced peripheral neuropathy in patients with advanced RCCY Loriot, C Massard, E Angevin, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|June 14, 2011
[Cancer stem cells: a new target for lung cancer treatment]S Rivera, C Rivera, Y Loriot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 14, 2015
EGFR-independent mechanisms of acquired resistance to AZD9291 in EGFR T790M-positive NSCLC patientsD Planchard, Y Loriot, F André, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 9, 2015
Enzalutamide and sleep apnea: an emerging central nervous system side-effect?F Labrize, L Cany, C Massard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 31, 2009
Combining carboplatin and etoposide in docetaxel-pretreated patients with castration-resistant prostate cancer: a prospective study evaluating also neuroendocrine featuresY Loriot, C Massard, M Gross-Goupil, et al.
Prostate Cancer and Prostatic Diseases|January 4, 2017
Skeletal-related events significantly impact health-related quality of life in metastatic castration-resistant prostate cancer: data from PREVAIL and AFFIRM trialsF Saad, C Ivanescu, D Phung, et al.
Pageof 8